Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

368
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
368
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

234
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
234
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

482
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
482
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

448
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
448
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

499
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
499
Overview of Synapses01:25

Overview of Synapses

2.4K
A synapse is a specialized structure where two neurons connect, allowing them to pass an electrical or chemical signal to another neuron. It is the point of communication between neurons. The term "synapse" is derived from the Greek word "synapsis," which means "conjunction." The entire process of neural communication revolves around the synapse. When activated, a neuron releases chemicals known as neurotransmitters into the synapse. These neurotransmitters cross the synapse and bind to...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controls on Development and Classification of Gypsum Mold-Vuggy Reservoirs: A Case Study from the Majiagou Formation, Jingbian Gas Field.

ACS omega·2026
Same author

Evaluation of genotype characteristics and drug resistance mutations in patients with chronic hepatitis B.

Scientific reports·2024
Same author

Multi-method characterization of groundwater nitrate and sulfate contamination by karst mines in southwest China.

The Science of the total environment·2024
Same author

Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster.

iScience·2022
Same author

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants.

Nature communications·2021
Same author

Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.

Journal of cancer research and clinical oncology·2021

Related Experiment Video

Updated: Aug 3, 2025

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.1K

Syntaxin 7 modulates seizure activity in epilepsy.

Junhong Wu1, Hui Zhang1, Liu Yang1

  • 1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, 1 Youyi Road, Chongqing 400016, China.

Neurobiology of Disease
|April 9, 2023
PubMed
Summary

Syntaxin7 (STX7) protein levels are reduced in epilepsy. Increasing STX7 expression reduces seizure susceptibility and activity, suggesting STX7 as a potential new epilepsy treatment target.

Keywords:
EpilepsyGABASynaptic transmissionSynaptic vesicleSyntaxin 7

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

33.3K

Related Experiment Videos

Last Updated: Aug 3, 2025

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.1K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

33.3K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Epilepsy is a common neurological disorder with complex and incompletely understood pathogenesis.
  • Syntaxin7 (STX7), a SNARE protein involved in membrane fusion, has an undefined role in epilepsy.

Purpose of the Study:

  • To investigate the role of Syntaxin7 (STX7) in the pathogenesis and potential treatment of epilepsy.

Main Methods:

  • Utilized kainic acid-induced and pentylenetetrazole-induced kindling epilepsy models.
  • Performed whole-cell patch-clamp recordings to assess neuronal excitability.
  • Employed transmission electron microscopy to examine synaptic structures.

Main Results:

  • STX7 expression was found to be decreased in epileptic brain tissue.
  • Overexpression of STX7 reduced seizure susceptibility and epileptic activity; downregulation had opposite effects.
  • STX7 influences the excitation/inhibition ratio by modulating presynaptic GABA release and inhibitory vesicle density, not intrinsic neuronal excitability or synapse density.

Conclusions:

  • STX7 plays a significant role in regulating neuronal excitability and neurotransmission in epilepsy.
  • STX7 represents a novel therapeutic target for managing epilepsy.